Various morphological types of fragmented ventricular premature beats on 12 lead Holter ECG had positive relationship with LV fibrotic volume on CMR in HCM subjects

Abstract

[1] Fox K, Garcia MAA, Ardissino D, et al. Guidelines on themanagement of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341–81. [2] Kolh P, Wijns W, Danchin N, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2010;38(Supplement 1):S1–S52. [3] Smeeth L, Skinner JS, Ashcroft J, Hemingway H, Timmis A. NICE clinical guideline: chest pain of recent onset. Br J Gen Pract 2010;60:607–10. [4] Cook S, Walker A, Hugli O, Togni M, Meier B. Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based on data up to 2004. Clin Res Cardiol 2007;96:375–82. [5] Maier W, Abay M, Cook S, et al. The 2002 European registry of cardiac catheter interventions. Int J Cardiol 2006;113:299–304. [6] Cook S, Walker A, Hugli O, et al. Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based on data up to 2004. Clin Res Cardiol 2007;96:375–82. [7] Hense HW. Risk factor scoring for coronary heart disease. BMJ 2003;327:1238–9. [8] Califf RM, Armstrong PW, Carver JR, D'Agostino RB, Strauss WE. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 1996;27:1007–19. [9] BodenWE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without pci for stable coronary disease. N Engl J Med 2007;356:1503–16. [10] Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010;122:949–57. [11] Lonn E, Bosch J, Teo KK, et al. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. Circulation 2010;122:2078–88.